Jefferies Financial Group started coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report published on Friday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $14.00 target price on the stock. Orchestra BioMed Stock Performance Shares of OBIO opened at $8.72 on Friday. The stock has a 50-day moving […]
Orchestra Biomed Holdings Inc. randomized the first patient in the BACKBEAT pivotal study investigating the use of its atrioventricular interval modulation (AVIM) therapy as a treatment for patients with uncontrolled hypertension implanted with a Medtronic plc pacemaker. AVIM therapy is an investigational patented bioelectronic therapy designed to immediately and durably reduce blood pressure.
Comparing Intelligent Bio Solutions (NASDAQ:INBS) & Orchestra BioMed (NASDAQ:OBIO) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and Orchestra BioMed (NASDAQ:OBIO – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Institutional and Insider Ownership 9.3% of […]